These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 24182859)

  • 1. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Katz JD; Jones OY
    Rheum Dis Clin North Am; 2013 Nov; 39(4):877-904. PubMed ID: 24182859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic inflammatory myopathies].
    Vencovský J
    Vnitr Lek; 2018; 64(2):155-163. PubMed ID: 29595280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on inflammatory myositis in children.
    Huber A; Feldman BM
    Curr Opin Rheumatol; 2013 Sep; 25(5):630-5. PubMed ID: 23912317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic Inflammatory Myopathies.
    Balan S; Madan S
    Indian J Pediatr; 2024 Oct; 91(10):1041-1048. PubMed ID: 37919486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A; Dankó K
    Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
    Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
    Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.
    Wu JQ; Lu MP; Reed AM
    World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.
    Rider LG; Nistala K
    J Intern Med; 2016 Jul; 280(1):24-38. PubMed ID: 27028907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Idiopathic Inflammatory Myopathies.
    Huber AM
    Pediatr Clin North Am; 2018 Aug; 65(4):739-756. PubMed ID: 30031496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
    Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
    Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and treatment of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Miller FW
    Rheum Dis Clin North Am; 1997 Aug; 23(3):619-55. PubMed ID: 9287380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.
    Pagnini I; Vitale A; Selmi C; Cimaz R; Cantarini L
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):34-44. PubMed ID: 26429707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the pharmacological treatment of adult myositis.
    Oddis CV
    J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.